Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system

被引:0
作者
Yang, Xueqian [1 ]
Wu, Meiqi [1 ]
Liang, Menglin [1 ]
Zhang, Haiqiong [1 ]
Li, Bo [2 ]
Mao, Chenhui [2 ]
Dong, Liling [2 ]
Wang, Yuan [1 ]
Xing, Haiqun [1 ]
Ren, Chao [1 ]
Huang, Zhenghai [1 ]
Wen, Qingxiang [3 ]
Ge, Qi [4 ]
Yu, Zhengqing [4 ]
Feng, Feng [5 ]
Gao, Jing [2 ]
Huo, Li [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Nucl Med,Beijing Key Lab Mol Targeted Diag &, Ctr Rare Dis Res,State Key Lab Complex Severe & Ra, 1 Shuaifuyuan, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurol, State Key Lab Complex Severe & Rare Dis, 1 Shuaifuyuan, Beijing 100730, Peoples R China
[3] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Beijing 100010, Peoples R China
[4] Cent Res Inst, United Imaging Healthcare, Shanghai 201807, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
Ultra-fast PET scan; beta-Amyloid; Digital PET/CT; F-18]florbetapir; Image quality; AMYLOID-BETA PLAQUES; ALZHEIMERS-DISEASE; FLORBETABEN;
D O I
10.1186/s40658-024-00712-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background There is a need for faster amyloid PET scans to reduce patients' discomfort, minimize movement artifacts, and increase throughput. The recently introduced uMI Panorama PET/CT system featuring enhanced spatial resolution and sub-200ps TOF offers the potential for shorter scan duration without sacrificing image quality or efficacy to detect A beta deposition. The study aims to establish a faster acquisition protocol for [F-18]florbetapir PET imaging using digital PET/CT scanner uMI Panorama, while ensuring adequate image quality and amyloid-beta (A beta) detectability comparable to the standard 10-minute scan. Methods Thirty-eight participants (29 A beta positive and 9 A beta negative) from a prospective dementia cohort at Peking Union Medical University Hospital underwent routine [F-18]florbetapir PET scans using the uMI Panorama PET/CT scanner and a T1-weighted brain MRI scan. List-mode PET data were reconstructed into durations of 10 min, 2 min, 1 min, 45 s, and 30 s (G10min, G2min, G1min, G45s, G30s). Two trained nuclear medicine physicians independently evaluated the image quality using a 5-point scale and provided binary diagnosis. Standardized uptake value ratios (SUVr) of the composite cortex (frontal, lateral parietal, lateral temporal, and cingulate cortices) were calculated to discriminate A beta status and coefficient of variation assessed objective image quality. Comparisons of image quality and A beta detectability between various fast scan groups and G10min group were conducted. Results The subjective image quality evaluation and A beta detectability results from the two physicians showed both good intra-reader and inter-reader agreements (Cohen's kappa coefficient: 0.759-1.000). The subjective and objective image qualities of the G2min scans were comparable to the G10min scans, whereas adequate image quality was achieved with the G1min and G45s scans (5-point score >= 3). Subjective visual diagnosis by two physicians yielded consistent accuracy for G10min, G2min, and G1min groups, but lower specificity for G45s and G30s groups. The objective detection of A beta status by cortex SUVr across all scan durations maintained perfect discriminatory efficiency and relatively high effect size (Hedge's G: 2.48-2.54). Conclusions A 1-min ultra-fast scan is feasible for [F-18]florbetapir PET imaging using uMI Panorama PET/CT, while maintaining adequate image quality and A beta diagnostic efficiency.
引用
收藏
页数:12
相关论文
共 33 条
[1]  
American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, DOI DOI 10.1176/APPI.BOOKS.9780890425596
[2]  
[Anonymous], ABOUT US
[3]   Clinical Use and Utility of Amyloid Imaging [J].
Barthel, Henryk ;
Sabri, Osama .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (11) :1711-1717
[4]   Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches [J].
Boxer, Adam L. ;
Yu, Jin-Tai ;
Golbe, Lawrence I. ;
Litvan, Irene ;
Lang, Anthony E. ;
Hoeglinger, Guenter U. .
LANCET NEUROLOGY, 2017, 16 (07) :552-563
[5]   The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review [J].
Chapleau, Marianne ;
Iaccarino, Leonardo ;
Soleimani-Meigooni, David ;
Rabinovici, Gil D. .
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 :13S-19S
[6]  
Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4
[7]   An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest [J].
Desikan, Rahul S. ;
Segonne, Florent ;
Fischl, Bruce ;
Quinn, Brian T. ;
Dickerson, Bradford C. ;
Blacker, Deborah ;
Buckner, Randy L. ;
Dale, Anders M. ;
Maguire, R. Paul ;
Hyman, Bradley T. ;
Albert, Marilyn S. ;
Killiany, Ronald J. .
NEUROIMAGE, 2006, 31 (03) :968-980
[8]   Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group [J].
Dubois, Bruno ;
Villain, Nicolas ;
Frisoni, Giovanni B. ;
Rabinovici, Gil D. ;
Sabbagh, Marwan ;
Cappa, Stefano ;
Bejanin, Alexandre ;
Bombois, Stephanie ;
Epelbaum, Stephane ;
Teichmann, Marc ;
Habert, Marie-Odile ;
Nordberg, Agneta ;
Blennow, Kaj ;
Galasko, Douglas ;
Stern, Yaakov ;
Rowe, Christopher C. ;
Salloway, Stephen ;
Schneider, Lon S. ;
Cummings, Jeffrey L. ;
Feldman, Howard H. .
LANCET NEUROLOGY, 2021, 20 (06) :484-496
[9]   Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease [J].
Honig, Lawrence S. ;
Vellas, Bruno ;
Woodward, Michael ;
Boada, Merce ;
Bullock, Roger ;
Borrie, Michael ;
Hager, Klaus ;
Andreasen, Niels ;
Scarpini, Elio ;
Liu-Seifert, Hong ;
Case, Michael ;
Dean, Robert A. ;
Hake, Ann ;
Sundell, Karen ;
Hoffmann, Vicki Poole ;
Carlson, Christopher ;
Khanna, Rashna ;
Mintun, Mark ;
DeMattos, Ronald ;
Selzler, Katherine J. ;
Siemers, Eric .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :321-330
[10]   NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease [J].
Jack, Clifford R., Jr. ;
Bennett, David A. ;
Blennow, Kaj ;
Carrillo, Maria C. ;
Dunn, Billy ;
Haeberlein, Samantha Budd ;
Holtzman, David M. ;
Jagust, William ;
Jessen, Frank ;
Karlawish, Jason ;
Liu, Enchi ;
Luis Molinuevo, Jose ;
Montine, Thomas ;
Phelps, Creighton ;
Rankin, Katherine P. ;
Rowe, Christopher C. ;
Scheltens, Philip ;
Siemers, Eric ;
Snyder, Heather M. ;
Sperling, Reisa ;
Elliott, Cerise ;
Masliah, Eliezer ;
Ryan, Laurie ;
Silverberg, Nina .
ALZHEIMERS & DEMENTIA, 2018, 14 (04) :535-562